ARB-treated women have higher risk of new-onset diabetes

04/22/2012 | Diabetes.co.uk (U.K.)

Hypertensive women who were prescribed angiotensin receptor blockers were 93% more likely to develop new-onset diabetes compared with those who received angiotensin-converting-enzyme inhibitors, a study in the Journal of Clinical Hypertension revealed. More study is needed, but the findings may aid in decision-making among clinicians, the lead researcher said.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide